BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

990 related articles for article (PubMed ID: 26377379)

  • 1. Long-term disease progression in spinocerebellar ataxia types 1, 2, 3, and 6: a longitudinal cohort study.
    Jacobi H; du Montcel ST; Bauer P; Giunti P; Cook A; Labrum R; Parkinson MH; Durr A; Brice A; Charles P; Marelli C; Mariotti C; Nanetti L; Panzeri M; Rakowicz M; Sulek A; Sobanska A; Schmitz-Hübsch T; Schöls L; Hengel H; Baliko L; Melegh B; Filla A; Antenora A; Infante J; Berciano J; van de Warrenburg BP; Timmann D; Szymanski S; Boesch S; Kang JS; Pandolfo M; Schulz JB; Molho S; Diallo A; Klockgether T
    Lancet Neurol; 2015 Nov; 14(11):1101-8. PubMed ID: 26377379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival in patients with spinocerebellar ataxia types 1, 2, 3, and 6 (EUROSCA): a longitudinal cohort study.
    Diallo A; Jacobi H; Cook A; Labrum R; Durr A; Brice A; Charles P; Marelli C; Mariotti C; Nanetti L; Panzeri M; Rakowicz M; Sobanska A; Sulek A; Schmitz-Hübsch T; Schöls L; Hengel H; Melegh B; Filla A; Antenora A; Infante J; Berciano J; van de Warrenburg BP; Timmann D; Boesch S; Pandolfo M; Schulz JB; Bauer P; Giunti P; Kang JS; Klockgether T; Tezenas du Montcel S
    Lancet Neurol; 2018 Apr; 17(4):327-334. PubMed ID: 29553382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conversion of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 to manifest ataxia (RISCA): a longitudinal cohort study.
    Jacobi H; du Montcel ST; Romanzetti S; Harmuth F; Mariotti C; Nanetti L; Rakowicz M; Makowicz G; Durr A; Monin ML; Filla A; Roca A; Schöls L; Hengel H; Infante J; Kang JS; Timmann D; Casali C; Masciullo M; Baliko L; Melegh B; Nachbauer W; Bürk-Gergs K; Schulz JB; Riess O; Reetz K; Klockgether T
    Lancet Neurol; 2020 Sep; 19(9):738-747. PubMed ID: 32822634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological and clinical characteristics of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 in the longitudinal RISCA study: analysis of baseline data.
    Jacobi H; Reetz K; du Montcel ST; Bauer P; Mariotti C; Nanetti L; Rakowicz M; Sulek A; Durr A; Charles P; Filla A; Antenora A; Schöls L; Schicks J; Infante J; Kang JS; Timmann D; Di Fabio R; Masciullo M; Baliko L; Melegh B; Boesch S; Bürk K; Peltz A; Schulz JB; Dufaure-Garé I; Klockgether T
    Lancet Neurol; 2013 Jul; 12(7):650-8. PubMed ID: 23707147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term evolution of patient-reported outcome measures in spinocerebellar ataxias.
    Jacobi H; du Montcel ST; Bauer P; Giunti P; Cook A; Labrum R; Parkinson MH; Durr A; Brice A; Charles P; Marelli C; Mariotti C; Nanetti L; Sarro L; Rakowicz M; Sulek A; Sobanska A; Schmitz-Hübsch T; Schöls L; Hengel H; Baliko L; Melegh B; Filla A; Antenora A; Infante J; Berciano J; van de Warrenburg BP; Timmann D; Szymanski S; Boesch S; Nachbauer W; Kang JS; Pandolfo M; Schulz JB; Melac AT; Diallo A; Klockgether T
    J Neurol; 2018 Sep; 265(9):2040-2051. PubMed ID: 29959555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spinocerebellar ataxia types 1, 2, 3, and 6: disease severity and nonataxia symptoms.
    Schmitz-Hübsch T; Coudert M; Bauer P; Giunti P; Globas C; Baliko L; Filla A; Mariotti C; Rakowicz M; Charles P; Ribai P; Szymanski S; Infante J; van de Warrenburg BP; Dürr A; Timmann D; Boesch S; Fancellu R; Rola R; Depondt C; Schöls L; Zdienicka E; Kang JS; Döhlinger S; Kremer B; Stephenson DA; Melegh B; Pandolfo M; di Donato S; du Montcel ST; Klockgether T
    Neurology; 2008 Sep; 71(13):982-9. PubMed ID: 18685131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The natural history of spinocerebellar ataxia type 1, 2, 3, and 6: a 2-year follow-up study.
    Jacobi H; Bauer P; Giunti P; Labrum R; Sweeney MG; Charles P; Dürr A; Marelli C; Globas C; Linnemann C; Schöls L; Rakowicz M; Rola R; Zdzienicka E; Schmitz-Hübsch T; Fancellu R; Mariotti C; Tomasello C; Baliko L; Melegh B; Filla A; Rinaldi C; van de Warrenburg BP; Verstappen CC; Szymanski S; Berciano J; Infante J; Timmann D; Boesch S; Hering S; Depondt C; Pandolfo M; Kang JS; Ratzka S; Schulz J; Tezenas du Montcel S; Klockgether T
    Neurology; 2011 Sep; 77(11):1035-41. PubMed ID: 21832228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency of SCA1, SCA2, SCA3/MJD, SCA6, SCA7, and DRPLA CAG trinucleotide repeat expansion in patients with hereditary spinocerebellar ataxia from Chinese kindreds.
    Tang B; Liu C; Shen L; Dai H; Pan Q; Jing L; Ouyang S; Xia J
    Arch Neurol; 2000 Apr; 57(4):540-4. PubMed ID: 10768629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disease progression of spinocerebellar ataxia types 1, 2, 3 and 6 before and after ataxia onset.
    Jacobi H; Schaprian T; Schmitz-Hübsch T; Schmid M; Klockgether T;
    Ann Clin Transl Neurol; 2023 Oct; 10(10):1833-1843. PubMed ID: 37592453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors influencing disease progression in autosomal dominant cerebellar ataxia and spastic paraplegia.
    Tezenas du Montcel S; Charles P; Goizet C; Marelli C; Ribai P; Vincitorio C; Anheim M; Guyant-Maréchal L; Le Bayon A; Vandenberghe N; Tchikviladzé M; Devos D; Le Ber I; N'Guyen K; Cazeneuve C; Tallaksen C; Brice A; Durr A
    Arch Neurol; 2012 Apr; 69(4):500-8. PubMed ID: 22491195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular genetics of hereditary spinocerebellar ataxia: mutation analysis of spinocerebellar ataxia genes and CAG/CTG repeat expansion detection in 225 Italian families.
    Brusco A; Gellera C; Cagnoli C; Saluto A; Castucci A; Michielotto C; Fetoni V; Mariotti C; Migone N; Di Donato S; Taroni F
    Arch Neurol; 2004 May; 61(5):727-33. PubMed ID: 15148151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural history of most common spinocerebellar ataxia: a systematic review and meta-analysis.
    Diallo A; Jacobi H; Tezenas du Montcel S; Klockgether T
    J Neurol; 2021 Aug; 268(8):2749-2756. PubMed ID: 32266540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular analysis of Spinocerebellar ataxias in Koreans: frequencies and reference ranges of SCA1, SCA2, SCA3, SCA6, and SCA7.
    Kim JY; Park SS; Joo SI; Kim JM; Jeon BS
    Mol Cells; 2001 Dec; 12(3):336-41. PubMed ID: 11804332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of CAG repeats in SCA1, SCA2, SCA3, SCA6, SCA7 and DRPLA loci in spinocerebellar ataxia patients and distribution of CAG repeats at the SCA1, SCA2 and SCA6 loci in nine ethnic populations of eastern India.
    Basu P; Chattopadhyay B; Gangopadhaya PK; Mukherjee SC; Sinha KK; Das SK; Roychoudhury S; Majumder PP; Bhattacharyya NP
    Hum Genet; 2000 Jun; 106(6):597-604. PubMed ID: 10942107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spinocerebellar ataxias types 1, 2 and 3: age adjusted clinical severity of disease at presentation correlates with size of CAG repeat lengths.
    Netravathi M; Pal PK; Purushottam M; Thennarasu K; Mukherjee M; Jain S
    J Neurol Sci; 2009 Feb; 277(1-2):83-6. PubMed ID: 19049837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparable progression of spinocerebellar ataxias between Caucasians and Chinese.
    Lin YC; Lee YC; Hsu TY; Liao YC; Soong BW
    Parkinsonism Relat Disord; 2019 May; 62():156-162. PubMed ID: 30591349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spinocerebellar ataxias in Spanish patients: genetic analysis of familial and sporadic cases. The Ataxia Study Group.
    Pujana MA; Corral J; Gratacòs M; Combarros O; Berciano J; Genís D; Banchs I; Estivill X; Volpini V
    Hum Genet; 1999 Jun; 104(6):516-22. PubMed ID: 10453742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The occurrence of spinocerebellar ataxias caused by dynamic mutations in Polish patients.
    Sułek-Piatkowska A; Zdzienicka E; Raczyńska-Rakowicz M; Krysa W; Rajkiewicz M; Szirkowiec W; Zaremba J
    Neurol Neurochir Pol; 2010; 44(3):238-45. PubMed ID: 20625959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characteristics of patients with spinocerebellar ataxias 1, 2, 3 and 6 in the US; a prospective observational study.
    Ashizawa T; Figueroa KP; Perlman SL; Gomez CM; Wilmot GR; Schmahmann JD; Ying SH; Zesiewicz TA; Paulson HL; Shakkottai VG; Bushara KO; Kuo SH; Geschwind MD; Xia G; Mazzoni P; Krischer JP; Cuthbertson D; Holbert AR; Ferguson JH; Pulst SM; Subramony SH
    Orphanet J Rare Dis; 2013 Nov; 8():177. PubMed ID: 24225362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A longitudinal investigation into cognition and disease progression in spinocerebellar ataxia types 1, 2, 3, 6, and 7.
    Moriarty A; Cook A; Hunt H; Adams ME; Cipolotti L; Giunti P
    Orphanet J Rare Dis; 2016 Jun; 11(1):82. PubMed ID: 27333979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 50.